It greatly increases anti-tumor activity in mice with a functional immune system by increasing the number of CD8-positive tumor-infiltrating lymphocytes in an AMPK-dependent manner (Eikawa et al., 2015). The gene discussed is CD8A; the disease is neoplasm.